This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vistide (Cidofovir) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (12)
Death (4)
Disability (1)
Reports by Reaction Type
Myelodysplastic Syndrome (4),
Therapeutic Response Decreased (4),
Drug Ineffective FOR Unapproved Indication (3),
Locked-in Syndrome (2),
Blindness Cortical (2),
Progressive Multifocal Leukoencephalopathy (2),
Glioma (1),
Ill-Defined Disorder (1),
Cardiac Disorder (1),
Pericardial Effusion (1),
Lung Disorder (1),
Bone Marrow Toxicity (1)
Possible Vistide side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-24
Patient:
Reactions: Drug Ineffective FOR Unapproved Indication
Adverse event resulted in: death
Drug(s) suspected as cause:
Vistide
Possible Vistide side effects in male
Reported by a physician from Finland on 2012-08-07
Patient: male
Reactions: Glioma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vistide
Possible Vistide side effects in male
Reported by a physician from Belgium on 2012-08-01
Patient: male
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 unknown, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
End date: 2012-04-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Mabthera; Solian; Medrol; Omeprazole; Neoral
Possible Vistide side effects in male
Reported by a physician from Belgium on 2012-07-25
Patient: male
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 unknown, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
End date: 2012-04-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Medrol; Solian; Mabthera; Omeprazole; Neoral
Possible Vistide side effects in 37 year old male
Reported by a physician from Belgium on 2012-07-04
Patient: 37 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 mug, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Mabthera; Medrol; Solian; Omeprazole; Neoral; Mabthera
Possible Vistide side effects in 20 year old male
Reported by a pharmacist from United Kingdom on 2012-06-28
Patient: 20 year old male
Reactions: Neutropenia, Ill-Defined Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Dosage: 2 df, bid
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-14
Vistide
Dosage: 370 mg, q1wk
Indication: Progressive Multifocal Leukoencephalopathy
Start date: 2012-03-28
End date: 2012-04-23
Vistide
Indication: JC Virus Infection
Zidovudine
Dosage: 250 mg, bid
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-14
End date: 2012-04-06
Other drugs received by patient: Saquinavir; Tenofovir Disoproxil Fumarate; Probenecid; Mirtazapine; Probenecid; Probenecid
Possible Vistide side effects in 37 year old male
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-06-26
Patient: 37 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Therapeutic Response Decreased, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Aranesp
Dosage: 500 mug, q3wk
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-01
Probenecid
Dosage: unk
Indication: Nephropathy Toxic
Start date: 2011-11-01
End date: 2012-04-01
Vistide
Dosage: unk
Indication: Cytomegalovirus Infection
Start date: 2011-11-01
End date: 2012-04-01
Other drugs received by patient: Solian; Medrol; Mabthera; Neoral; Omeprazole; Mabthera
Possible Vistide side effects in 23 year old male
Reported by a physician from Germany on 2012-06-14
Patient: 23 year old male
Reactions: Drug Ineffective FOR Unapproved Indication
Drug(s) suspected as cause:
Vistide
Dosage: 5 mg/kg, q2wk
Vistide
Dosage: 5 mg/kg, q1wk
Indication: Skin Papilloma
Other drugs received by patient: Aspirin; Fluorouracil; Probenecid
Possible Vistide side effects in 32 year old male
Reported by a individual with unspecified qualification from Portugal on 2012-03-23
Patient: 32 year old male
Reactions: Locked-in Syndrome, Blindness Cortical, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Vistide
Possible Vistide side effects in female
Reported by a physician from Germany on 2012-03-23
Patient: female
Reactions: Lung Disorder, Cardiac Disorder, Pericardial Effusion
Drug(s) suspected as cause:
Vistide
Possible Vistide side effects in 32 year old male
Reported by a health professional (non-physician/pharmacist) from Portugal on 2012-03-19
Patient: 32 year old male
Reactions: Locked-in Syndrome, Blindness Cortical, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Vistide
Possible Vistide side effects in 10 year old male
Reported by a individual with unspecified qualification from Italy on 2012-01-18
Patient: 10 year old male
Reactions: Drug Ineffective FOR Unapproved Indication, Bone Marrow Toxicity
Adverse event resulted in: death
Drug(s) suspected as cause:
Vistide
Other drugs received by patient: Acyclovir; Foscarnet
|
